Zerodha (Trading & Demat Account)
FREE Equity Delivery and MF
Flat ₹20/trade Intra-day/F&O
Zerodha (Trading & Demat Account)
FREE Equity Delivery and MF
Flat ₹20/trade Intra-day/F&O
|
|
Kronox Lab Sciences IPO is a book built issue of Rs 130.15 crores. The issue is entirely an offer for sale of 0.96 crore shares.
Kronox Lab Sciences IPO bidding started from June 3, 2024 and ended on June 5, 2024. The allotment for Kronox Lab Sciences IPO was finalized on Thursday, June 6, 2024. The shares got listed on BSE, NSE on June 10, 2024.
Kronox Lab Sciences IPO price band is set at ₹129 to ₹136 per share. The minimum lot size for an application is 110 Shares. The minimum amount of investment required by retail investors is ₹14,960. The minimum lot size investment for sNII is 14 lots (1,540 shares), amounting to ₹209,440, and for bNII, it is 67 lots (7,370 shares), amounting to ₹1,002,320.
Pantomath Capital Advisors Pvt Ltd is the book running lead manager of the Kronox Lab Sciences IPO, while Kfin Technologies Limited is the registrar for the issue.
Refer to Kronox Lab Sciences IPO RHP for detailed information.
| IPO Date | June 3, 2024 to June 5, 2024 |
| Listing Date | June 10, 2024 |
| Face Value | ₹10 per share |
| Price Band | ₹129 to ₹136 per share |
| Lot Size | 110 Shares |
| Total Issue Size | 9,570,000 shares (aggregating up to ₹130.15 Cr) |
| Offer for Sale | 9,570,000 shares of ₹10 (aggregating up to ₹130.15 Cr) |
| Issue Type | Book Built Issue IPO |
| Listing At | BSE, NSE |
| Share holding pre issue | 37,104,000 |
| Share holding post issue | 37,104,000 |
Kronox Lab Sciences IPO offers 9,570,000 shares. 1,914,000 (20.00%) to QIB, 1,435,500 (15.00%) to NII, 3,349,500 (35.00%) to RII and 2,871,000 (30.00%) to Anchor investors. 30,450 RIIs will receive minimum 110 shares and 310 (sNII) and 621 (bNII) will receive minimum 1,540 shares. (in case of oversubscription)
| Investor Category | Shares Offered | Maximum Allottees |
|---|---|---|
| Anchor Investor Shares Offered | 2,871,000 (30.00%) | NA |
| QIB Shares Offered | 1,914,000 (20.00%) | NA |
| NII (HNI) Shares Offered | 1,435,500 (15.00%) | |
| bNII > ₹10L | 957,000 (10.00%) | 621 |
| sNII < ₹10L | 478,500 (5.00%) | 310 |
| Retail Shares Offered | 3,349,500 (35.00%) | 30,450 |
| Total Shares Offered | 9,570,000 (100%) |
Kronox Lab Sciences IPO raises Rs 39.05 crore from anchor investors. Kronox Lab Sciences IPO Anchor bid date is May 31, 2024. Kronox Lab Sciences IPO Anchor Investors list
| Bid Date | May 31, 2024 |
| Shares Offered | 2,871,000 |
| Anchor Portion Size (In Cr.) | 39.05 |
| Anchor lock-in period end date for 50% shares (30 Days) | July 6, 2024 |
| Anchor lock-in period end date for remaining shares (90 Days) | September 4, 2024 |
Kronox Lab Sciences IPO opens on June 3, 2024, and closes on June 5, 2024.
| IPO Open Date | Monday, June 3, 2024 |
| IPO Close Date | Wednesday, June 5, 2024 |
| Basis of Allotment | Thursday, June 6, 2024 |
| Initiation of Refunds | Friday, June 7, 2024 |
| Credit of Shares to Demat | Friday, June 7, 2024 |
| Listing Date | Monday, June 10, 2024 |
| Cut-off time for UPI mandate confirmation | 5 PM on June 5, 2024 |
Investors can bid for a minimum of 110 shares and in multiples thereof. The below table depicts the minimum and maximum investment by retail investors and HNI in terms of shares and amount.
| Application | Lots | Shares | Amount |
|---|---|---|---|
| Retail (Min) | 1 | 110 | ₹14,960 |
| Retail (Max) | 13 | 1430 | ₹194,480 |
| S-HNI (Min) | 14 | 1,540 | ₹209,440 |
| S-HNI (Max) | 66 | 7,260 | ₹987,360 |
| B-HNI (Min) | 67 | 7,370 | ₹1,002,320 |
| Lot Size Calculator | |||
The Promoters of the Company are Jogindersingh Jaswal, Ketan Ramani and Pritesh Ramani.
| Share Holding Pre Issue | 99.98% |
| Share Holding Post Issue | 74.21% |
Incorporated in 2008, Kronox Lab Sciences Limited is a manufacturer of high-purity speciality fine chemicals for diverse end-user industries. The company's High Purity Specialty Fine Chemicals are used in various applications such as manufacturing APIs, pharmaceutical formulations, scientific research, nutraceuticals, biotech applications, agrochemical formulations, personal care products, metal refineries, and animal health products.
The company offers a wide range of over 185 products, including phosphate, sulphate, acetate, chloride, citrate, nitrates, nitrites, carbonate, EDTA derivatives, hydroxide, succinate, gluconate, and others. These products are supplied to customers in India and more than 20 countries worldwide.
The company exports its products to countries such as United States, Argentina, Mexico, Australia, Egypt, Spain, Turkey, United Kingdom, Belgium, United Arab Emirates, China, among others.
The company has three manufacturing facilities in Vadodara, Gujarat, close to the seaports of Mundra, Kandla, Hazira, and Nhava Sheva. The facilities cover 17,454 sq. m. and have an installed capacity of 7,242 TPA as of December 31, 2023. Unit I/II holds FSSC 22000 (Version 5), ISO 9001:2015, ISO 14001:2015, and ISO 45001:2018 certifications. Additionally, some products manufactured at Unit I have obtained Kosher, Halal, GMP, and GLP certifications.
As of December 31, 2023, the company is conducting research and development on 122 products.
The company has served over 592 customers in the past three years. By December 31, 2023, 141 customers of the total, placed repeat orders.
As of December 31, 2023, the company employees 212 people at various levels.
Kronox Lab Sciences Limited's revenue increased by 16.99% and profit after tax (PAT) rose by 21.94% between the financial year ending with March 31, 2023 and March 31, 2022.
| Period Ended | 31 Dec 2023 | 31 Mar 2023 | 31 Mar 2022 | 31 Mar 2021 |
| Assets | 66.96 | 54.03 | 56.79 | 37.65 |
| Revenue | 68.44 | 97.50 | 83.34 | 63.24 |
| Profit After Tax | 15.47 | 16.62 | 13.63 | 9.73 |
| Net Worth | 60.28 | 44.68 | 40.35 | 26.81 |
| Reserves and Surplus | 15.56 | 7.58 | 40.11 | 26.57 |
| Total Borrowing | 0.64 | 0.01 | ||
| Amount in ₹ Crore | ||||
The market capitalization of Kronox Lab Sciences IPO is Rs 504.61 Cr.
KPI as of December 31, 2023.
| KPI | Values |
|---|---|
| ROE | 25.66% |
| ROCE | 33.15% |
| RoNW | 25.66% |
| P/BV | 8.37 |
| PAT Margin (%) | 22.6 |
| Pre IPO | Post IPO | |
|---|---|---|
| EPS (Rs) | 4.48 | 5.56 |
| P/E (x) | 30.37 | 24.47 |
The Objects of the Offer are to:
[Dilip Davda] The company is in high-purity speciality chemical segment and enjoys virtual monopoly in certain products. Its product portfolio currently has 185 products and another 122 is in the pipeline. Based on FY24 annualized earnings, the issue appears fully priced. Investors may park funds for the medium to long term rewards. Read detail review...
The Kronox Lab Sciences IPO is subscribed 117.25 times on June 5, 2024 6:19:05 PM. The public issue subscribed 54.24 times in the retail category, 89.03 times in the QIB category, and 301.92 times in the NII category. Check Day by Day Subscription Details (Live Status)
| Category | Subscription (times) |
|---|---|
| QIB | 89.03 |
| NII | 301.92 |
| bNII (bids above ₹10L) | 322.26 |
| sNII (bids below ₹10L) | 261.22 |
| Retail | 54.24 |
| Total | 117.25 |
Total Application : 1,528,029 (50.18 times)
| Listing Date | June 10, 2024 |
| BSE Script Code | 544187 |
| NSE Symbol | KRONOX |
| ISIN | INE0ATZ01017 |
| Final Issue Price | ₹136 per share |
| Price Details |
|---|
| Final Issue Price |
| Open |
| Low |
| High |
| Last Trade |
| BSE |
|---|
| ₹136.00 |
| ₹151.40 |
| ₹151.40 |
| ₹156.20 |
| ₹151.40 |
| NSE |
|---|
| ₹136.00 |
| ₹151.35 |
| ₹151.35 |
| ₹158.20 |
| ₹151.35 |
Kronox Lab Sciences Limited
Block No. 353,
Village Ekalbara, Padra,
Vadodara-391440
Phone: +91 26 6224 4077/88
Email: cs@kronoxlabsciences.com
Website: https://www.kronoxlabsciences.com/
Kfin Technologies Limited
Phone: 04067162222, 04079611000
Email: klsl.ipo@kfintech.com
Website: https://kosmic.kfintech.com/ipostatus/
Kronox Lab Sciences IPO is a main-board IPO of 9,570,000 equity shares of the face value of ₹10 aggregating up to ₹130.15 Crores. The issue is priced at ₹129 to ₹136 per share. The minimum order quantity is 110 Shares.
The IPO opens on June 3, 2024, and closes on June 5, 2024.
Kfin Technologies Limited is the registrar for the IPO. The shares are proposed to be listed on BSE, NSE.
Zerodha customers can apply online in Kronox Lab Sciences IPO using UPI as a payment gateway. Zerodha customers can apply in Kronox Lab Sciences IPO by login into Zerodha Console (back office) and submitting an IPO application form.
Steps to apply in Kronox Lab Sciences IPO through Zerodha
Visit Zerodha IPO Application Process Review for more detail.
The Kronox Lab Sciences IPO opens on June 3, 2024 and closes on June 5, 2024.
Kronox Lab Sciences IPO lot size is 110 Shares, and the minimum amount required is ₹14,960.
You can apply in Kronox Lab Sciences IPO online using either UPI or ASBA as payment method. ASBA IPO application is available in the net banking of your bank account. UPI IPO application is offered by brokers who don't offer banking services. Read more detail about apply IPO online through Zerodha, Upstox, 5Paisa, Nuvama, ICICI Bank, HDFC Bank and SBI Bank.
The finalization of Basis of Allotment for Kronox Lab Sciences IPO will be done on Thursday, June 6, 2024, and the allotted shares will be credited to your demat account by Friday, June 7, 2024. Check the Kronox Lab Sciences IPO allotment status.
Useful Articles
FREE Intraday Trading (Eq, F&O)
Flat ₹20 Per Trade in F&O
|
|
RHP
